MML Investors Services
BNTX icon

MML Investors Services’s BioNTech BNTX Stock Holding History

MML Investors Services’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,736
Closed -$220K – 2582
2024
Q2 		$220K Sell
2,736
-727
-21% -$66.5K ﹤0.01% 2298
2024
Q1 		$319K Buy
3,463
+518
+18% +$49.7K ﹤0.01% 2066
2023
Q4 		$311K Buy
+2,945
New +$297K ﹤0.01% 2024
2023
Q1 		– Sell
-3,473
Closed -$522K – 2098
2022
Q4 		$522K Buy
+3,473
New +$534K ﹤0.01% 1489
2021
Q3 		– Sell
-1,377
Closed -$308K – 1951
2021
Q2 		$308K Buy
+1,377
New +$260K ﹤0.01% 1599

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MML Investors Services's BNTX Position: Q3 2024 in Review

MML Investors Services sold out of BioNTech (BNTX) in Q3 2024, closing a stake of 2,736 shares — an estimated $220K sold.

MML Investors Services first reported a position in BNTX in Q2 2021 and held it in 5 quarters. The position peaked at $522K in Q4 2022. 296 funds tracked by Wall St. Rank hold BNTX as of Q3 2024.

  • MML Investors Services reported no remaining BioNTech position as of Q3 2024 after selling out during the quarter.
  • MML Investors Services sold 2,736 BioNTech shares in Q3 2024, an estimated $220K.
  • MML Investors Services first reported a position in BioNTech in Q2 2021 and held it in 5 quarters.
  • MML Investors Services's BioNTech position peaked at $522K in Q4 2022.
  • 296 funds tracked by Wall St. Rank held BioNTech as of Q3 2024.

Based on MML Investors Services's 13F filing for Q3 2024, filed 15 Nov 2024.